TRIM25 and neoplasm: Using in vivo tumor model of athymic mice, the Efp-specific siRNA suppresses the proliferation of Ishikawa-derived subcutaneous tumors by direct injection and HEC-1A-derived orthotopic tumors by intravenous administration.